Imunon, Inc. Gain (Loss) on Sale of Securities, Net (Deprecated 2018-01-31)
Imunon, Inc. (IMNN) reported Gain (Loss) on Sale of Securities, Net (Deprecated 2018-01-31) of -$532 for the 12-month period ending 2016-12-31, per its 10-K filed 2018-03-27.
Discontinued › Income Statement › Other Income
us-gaap:GainLossOnSaleOfSecuritiesNet · last filed 2018-03-27
- Imunon, Inc. gain (loss) on sale of securities, net (deprecated 2018-01-31) for the quarter ending 2016-12-31 was $3.33K, a 803.80% increase year-over-year.
- Imunon, Inc. gain (loss) on sale of securities, net (deprecated 2018-01-31) for the quarter ending 2016-09-30 was $0.00, a 100.00% decline year-over-year.
- Imunon, Inc. gain (loss) on sale of securities, net (deprecated 2018-01-31) for the quarter ending 2016-06-30 was $0.00.
- Imunon, Inc. gain (loss) on sale of securities, net (deprecated 2018-01-31) for the quarter ending 2016-03-31 was -$3.86K, a 3090.70% decline year-over-year.
- Imunon, Inc. gain (loss) on sale of securities, net (deprecated 2018-01-31) for fiscal 2016 was -$532.00, a 301.52% decline from fiscal 2015.
- Imunon, Inc. gain (loss) on sale of securities, net (deprecated 2018-01-31) for fiscal 2015 was $264.00.
- Imunon, Inc. gain (loss) on sale of securities, net (deprecated 2018-01-31) for fiscal 2014 was -$24.73K.
- Imunon, Inc. gain (loss) on sale of securities, net (deprecated 2018-01-31) for fiscal 2013 was -$92.36K.
| Period end | Gain (Loss) on Sale of Securities, Net (Deprecated 2018-01-31) 3 month | Gain (Loss) on Sale of Securities, Net (Deprecated 2018-01-31) 3 month as first filed | Gain (Loss) on Sale of Securities, Net (Deprecated 2018-01-31) 6 month | Gain (Loss) on Sale of Securities, Net (Deprecated 2018-01-31) 9 month | Gain (Loss) on Sale of Securities, Net (Deprecated 2018-01-31) 12 month |
|---|---|---|---|---|---|
| 2016-12-31 | $3.33K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-27 | $3.33K derived: sum of 2 quarters · filed 2018-03-27 | $3.33K derived: sum of 3 quarters · filed 2018-03-27 | -$532.00 10-K · filed 2018-03-27 | |
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-14 | $0.00 derived: sum of 2 quarters · filed 2017-11-14 | -$3.86K 10-Q · filed 2017-11-14 | -$3.49K derived: sum of 4 quarters · filed 2017-11-14 | |
| 2016-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-14 | -$3.86K 10-Q · filed 2017-08-14 | -$3.49K derived: sum of 3 quarters · filed 2017-08-14 | -$3.38K derived: sum of 4 quarters · filed 2017-08-14 | |
| 2016-03-31 | -$3.86K 10-Q · filed 2017-05-12 | -$3.49K derived: sum of 2 quarters · filed 2017-05-12 | -$3.38K derived: sum of 3 quarters · filed 2017-05-12 | -$3.72K derived: sum of 4 quarters · filed 2017-05-12 | |
| 2015-12-31 | $368.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-24 | $474.00 derived: sum of 2 quarters · filed 2017-03-24 | $135.00 derived: sum of 3 quarters · filed 2017-03-24 | $264.00 10-K · filed 2017-03-24 | |
| 2015-09-30 | $106.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10 | -$233.00 derived: sum of 2 quarters · filed 2016-11-10 | -$104.00 10-Q · filed 2016-11-10 | -$1.36K derived: sum of 4 quarters · filed 2016-11-10 | |
| 2015-06-30 | -$339.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-15 | -$210.00 10-Q · filed 2016-08-15 | -$1.46K derived: sum of 3 quarters · filed 2016-08-15 | -$1.25K derived: sum of 4 quarters · filed 2016-08-15 | |
| 2015-03-31 | $129.00 10-Q · filed 2016-05-16 | -$129.00 10-Q · filed 2015-05-11 | -$1.13K derived: sum of 2 quarters · filed 2016-05-16 | -$907.00 derived: sum of 3 quarters · filed 2016-05-16 | -$45.22K derived: sum of 4 quarters · filed 2016-05-16 |
| 2014-12-31 | -$1.25K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-30 | -$1.04K derived: sum of 2 quarters · filed 2016-03-30 | -$45.35K derived: sum of 3 quarters · filed 2016-03-30 | -$24.73K 10-K · filed 2016-03-30 | |
| 2014-09-30 | $218.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-05 | -$44.09K derived: sum of 2 quarters · filed 2015-11-05 | -$23.47K 10-Q · filed 2015-11-05 | $183.56K derived: sum of 4 quarters · filed 2016-03-30 | |
| 2014-06-30 | -$44.31K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-10 | -$23.69K 10-Q · filed 2015-08-10 | $183.35K derived: sum of 3 quarters · filed 2016-03-30 | $74.63K derived: sum of 4 quarters · filed 2016-03-30 | |
| 2014-03-31 | $20.62K 10-Q · filed 2015-05-11 | $227.66K derived: sum of 2 quarters · filed 2016-03-30 | $118.94K derived: sum of 3 quarters · filed 2016-03-30 | ||
| 2013-12-31 | $207.04K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-30 | $98.32K derived: sum of 2 quarters · filed 2016-03-30 | -$92.36K 10-K · filed 2016-03-30 | ||
| 2013-09-30 | -$108.72K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-10 | -$299.40K 10-Q · filed 2014-11-10 | |||
| 2013-06-30 | -$190.68K 10-Q · filed 2014-08-07 | ||||
| 2012-12-31 | -$7.58K 10-K · filed 2015-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |